|
2002 Journal Article The progesterone receptor exon 4 Va1660Leu G/T polymorphism and risk of breast cancer in Australian womenSpurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, McCredie, Margaret R. E., Giles, Graham G., Venter, Deon J., Southey, Melissa C. and Chenevix-Trench, Georgia (2002). The progesterone receptor exon 4 Va1660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiology Biomarkers & Prevention, 11 (5), 439-443. |
|
2001 Journal Article The steroid 5α-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian womenSpurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, Dite, Gillian S., McCredie, Margaret R. E., Giles, Graham G., Venter, Deon J., Southey, Melissa C., Purdie, David M. and Chenevix-Trench, Georgia (2001). The steroid 5α-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer Epidemiology, Biomarkers and Prevention, 10 (12), 1287-1293. |
|
2001 Journal Article No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancerSpurdle, Amanda B., Webb, Penelope M., Purdie, David M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. Carcinogenesis, 22 (5), 717-721. doi: 10.1093/carcin/22.5.717 |
|
2001 Journal Article The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in AustraliaMarsh, Anna, Spurdle, Amanda B., Turner, Bruce C., Fereday, Sian, Thorne, Heather, Pupo, Gulietta M., Mann, Graham J., Hopper, John L., Sambrook, Joseph F., Chenevix-Trench, Georgia, Australian Breast Canc Family Stud and K Cunningham Fdn Consortium Res Fa (2001). The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia. Breast Cancer Research, 3 (5) 346, 346-349. doi: 10.1186/bcr319 |
|
2001 Journal Article Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtypeSpurdle, Amanda B., Webb, Penelope M., Purdie, David M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis, 22 (1), 67-72. doi: 10.1093/carcin/22.1.67 |
|
2001 Journal Article The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancerSpurdle, Amanda B., Purdie, David M., Webb, Penelope M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer. Molecular Carcinogenesis, 30 (1), 71-78. doi: 10.1002/1098-2744(200101)30:13.0.CO;2-9 |
|
2000 Journal Article CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsSpurdle, Amanda B., Hopper, John L., Dite, Gillian S, Chen, Xiaoqing, Cui, Jisheng, McCredie, Margaret R. E., Giles, Graham G., Southey, Melissa C., Venter, Deon J., Easton, Douglas F. and Chenevix-Trench, Georgia (2000). CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. Journal of the National Cancer Institute, 92 (20), 1674-1681. doi: 10.1093/jnci/92.20.1674 |
|
2000 Journal Article CYP17 promotor polymorphism and ovarian cancer riskSpurdle, Amanda B., Chen, Xiaoqing, Abbazadegan, Mohammed, Martin, Nicholas, Khoo, Soo-Keat, Hurst, Terry, Ward, Bruce, Webb, Penelope M. and Chenevix-Trench, Georgia (2000). CYP17 promotor polymorphism and ovarian cancer risk. International Journal of Cancer, 89 (2), 436-439. |
|
2000 Journal Article CYP17 promotor polymorphism and ovarian cancer riskSpurdle, Amanda B., Chen, Xiaoqing, Abbazadegan, Mohammed, Martin, Nicholas, Khoo, Soo-Keat, Hurst, Terry, Ward, Bruce, Webb, Penelope M. and Chenevix-Trench, Georgia (2000). CYP17 promotor polymorphism and ovarian cancer risk. International Journal of Cancer, 86 (3), 436-439. doi: 10.1002/(SICI)1097-0215(20000501)86:33.0.CO;2-A |
|
2000 Journal Article Androgen receptor EXON 1 CAG repeat length and risk of ovarian cancerSpurdle, A. B., Webb, P. M., Chen, X. D., Martin, N. G., Giles, G. G., Hopper, J. L. and Chenevix-Trench, G. (2000). Androgen receptor EXON 1 CAG repeat length and risk of ovarian cancer. International Journal of Cancer, 87 (5), 637-643. doi: 10.1002/1097-0215(20000901)87:53.0.CO;2-R |
|
1999 Journal Article Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsSpurdle, A. B., Dite, G. S., Chen, X. Q., Mayne, C. J., Southey, M. C., Batten, L. E., Chy, H., Trute, L, McCredie, M. R. E., Giles, G. G., Armes, J., Venter, D. J., Hopper, J. L. and Chenevix-Trench, G. (1999). Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. Journal of the National Cancer Institute, 91 (11), 961-966. doi: 10.1093/jnci/91.11.961 |
|
1999 Journal Article Number of X-linked androgen receptor gene CAG repeats and femininity in women.Loehlin, J. C., Spurdle, A. B., Treloar, S. A. and Martin, N. G. (1999). Number of X-linked androgen receptor gene CAG repeats and femininity in women.. Personality & Individual Differences, 27 (5), 887-899. doi: 10.1016/S0191-8869(99)00038-0 |
